NCT06102161

Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)

Wedge Resection for Ground-glass Opacity-featured Lung Cancer With Size Less Than 2cm and Consolidation-to-tumor Ratio Between 0.25 to 0.5: a Single-arm, Multi-center, Prospective, Confirmatory Phase III Trial

• Status: Not Yet Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 286 (estimated)
• Sponsor: Fudan University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This is a clinical trial from the Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1020. The goal of this clinical trial is to confirm the therapeutic effect of Wedge resection for ground-glass opacity-featured lung cancer with a size less than 2cm and a consolidation-to-tumor ratio between 0.25 to 0.5.

Conditions

• Lung Cancer
• Wedge Resection
• Ground-glass Opacity

Interventions

Type	Name	Description
PROCEDURE	Wedge resection	Wedge resection is a surgical procedure that is done to remove a wedge-shaped section of lung tissue, usually for treating lung cancer. A wedge resection is less invasive than some of the other surgical options used to remove lung cancer.

Timeline

• Start date: 2023-11-01
• Primary completion: 2025-11-01
• Completion: 2030-11-01
• First posted: 2023-10-26
• Last updated: 2023-10-26

Locations

1 site across 1 country: China